漢王科技(002362.SZ):下半年將推出多款柯氏音血壓計新品
格隆匯7月2日丨漢王科技(002362.SZ)於近期投資者關係活動表示,今年,公司會面向C端市場推出電紙本系列、柯氏音血壓計系列、數字繪畫平板系列、仿生飛行機器鳥和四足機器狗等等衆多新品,同時對漢王掃描王App等進行持續更新迭代。
今年下半年,公司也將推出多款柯氏音血壓計新品,通過柯氏音+房顫檢測增加產品競爭力,完善我們血壓計產品體系,並且將價格區間覆蓋至200元起的主流價位段,爲用戶、合作夥伴和渠道市場提供更豐富的選擇。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.